Randomised phase II study of epirubicin-vindesine versus mitoxantrone-vindesine in metastatic breast cancerH. Hausmaninger, Georg Kemmler, Michael Fridrik et al.|European Journal of Cancer|1995Cited by 11
Vindesine-Epirubicin versus Vindesine-Mitoxantrone in Metastatic Breast CancerH. Hausmaninger, A Neiss, M. Lehnert et al.|Onkologie|2009Cited by 8
Vindesine-Mitoxantrone (VM) Versus Vindesine-4′-Epidoxorubicin (VE) in Metastatic Breast Cancer: A Prospective Randomized TrialH. Hausmaninger, M. Lehnert|Onkologie|2009Cited by 0